Journal of Immunology Research / 2014 / Article / Fig 1

Review Article

JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis

Figure 1

The mechanism of action of tofacitinib. JAK: Janus family kinase.
283617.fig.001

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.